Toward Personalized Therapy for Cancer
作者： Sarah J. Welsh , BM Bch
DOI: 10.1007/978-1-60327-424-1_20
关键词:
摘要: Personalized medicine is a model for the way will evolve through use of specific treatments and therapies best suited to an individual’s genotype. It driven by patient demand safer more effective medicines therapies. This chapter focuses on role personalized in cancer explores its current clinical practice, likely application future, challenges be overcome achieve this goal. Economic, social, ethical considerations relating are also discussed.
springer.com
sci-hub.st 参考文章(86)
T. Samoylova, N. Morrison, L. Globa, N. Cox, Arthur Frankel, Thomas Bugge, Shihui Liu, Daniel Vallera, Stephen Leppla, Peptide Phage Display: Opportunities for Development of Personalized Anti-Cancer Strategies Anti-cancer Agents in Medicinal Chemistry. ,vol. 6, pp. 9- 17 ,(2005) , 10.2174/187152006774755492
M Findlay, H Young, D Cunningham, A Iveson, B Cronin, T Hickish, B Pratt, J Husband, M Flower, R Ott, Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. Journal of Clinical Oncology. ,vol. 14, pp. 700- 708 ,(1996) , 10.1200/JCO.1996.14.3.700
Holger Breithaupt, The future of medicine EMBO reports. ,vol. 2, pp. 465- 467 ,(2001) , 10.1093/EMBO-REPORTS/KVE121
Peter M. Smith-Jones, David Solit, Neal Rosen, Farzana Afroze, Steven M. Larson, Early Tumor Response to Hsp90 Therapy Using HER2 PET: Comparison with 18F-FDG PET The Journal of Nuclear Medicine. ,vol. 47, pp. 793- 796 ,(2006)
Tetsuro Kubota, Gastrointestinal stromal tumor (GIST) and imatinib. International Journal of Clinical Oncology. ,vol. 11, pp. 184- 189 ,(2006) , 10.1007/S10147-006-0579-0
Takuro Nakamura, Yukihito Ishizaka, Minako Nagao, Mitsuru Hara, Takatoshi Ishikawa, Expression of the ret proto‐oncogene product in human normal and neoplastic tissues of neural crest origin The Journal of Pathology. ,vol. 172, pp. 255- 260 ,(1994) , 10.1002/PATH.1711720305
Janet S. Rasey, Wui-jin Koh, Margaret L. Evans, Lanell M. Peterson, Thomas K. Lewellen, Michael M. Graham, Kenneth A. Krohn, Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients International Journal of Radiation Oncology Biology Physics. ,vol. 36, pp. 417- 428 ,(1996) , 10.1016/S0360-3016(96)00325-2
Heather G. Keen, Bronwen A. Dekker, Lynn Disley, David Hastings, Steve Lyons, Andrew J. Reader, Penny Ottewell, Alastair Watson, Jamal Zweit, Imaging apoptosis in vivo using 124I-annexin V and PET. Nuclear Medicine and Biology. ,vol. 32, pp. 395- 402 ,(2005) , 10.1016/J.NUCMEDBIO.2004.12.008
Anthony F. Shields, John R. Grierson, Bernhard M. Dohmen, H.-Juergen Machulla, Joseph C. Stayanoff, Jawana M. Lawhorn-Crews, Joyce E. Obradovich, Otto Muzik, Thomas J. Mangner, Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nature Medicine. ,vol. 4, pp. 1334- 1336 ,(1998) , 10.1038/3337
Moshe Talpaz, Neil P. Shah, Hagop Kantarjian, Nicholas Donato, John Nicoll, Ron Paquette, Jorge Cortes, Susan O'Brien, Claude Nicaise, Eric Bleickardt, M. Anne Blackwood-Chirchir, Vishwanath Iyer, Tai-Tsang Chen, Fei Huang, Arthur P. Decillis, Charles L. Sawyers, Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias The New England Journal of Medicine. ,vol. 354, pp. 2531- 2541 ,(2006) , 10.1056/NEJMOA055229